ATE495439T1 - Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren - Google Patents

Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren

Info

Publication number
ATE495439T1
ATE495439T1 AT05785092T AT05785092T ATE495439T1 AT E495439 T1 ATE495439 T1 AT E495439T1 AT 05785092 T AT05785092 T AT 05785092T AT 05785092 T AT05785092 T AT 05785092T AT E495439 T1 ATE495439 T1 AT E495439T1
Authority
AT
Austria
Prior art keywords
point source
cells
methods
testing apparatus
cell activity
Prior art date
Application number
AT05785092T
Other languages
English (en)
Inventor
Richard Goodwin
Original Assignee
Neuro Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuro Probe Inc filed Critical Neuro Probe Inc
Application granted granted Critical
Publication of ATE495439T1 publication Critical patent/ATE495439T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502761Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5029Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0874Three dimensional network
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0887Laminated structure
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0472Diffusion
AT05785092T 2004-08-12 2005-08-11 Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren ATE495439T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60078304P 2004-08-12 2004-08-12
PCT/US2005/028546 WO2006020766A2 (en) 2004-08-12 2005-08-11 Point source diffusion cell activity assay apparatuses and methods

Publications (1)

Publication Number Publication Date
ATE495439T1 true ATE495439T1 (de) 2011-01-15

Family

ID=35908137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05785092T ATE495439T1 (de) 2004-08-12 2005-08-11 Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren

Country Status (9)

Country Link
US (3) US7547525B2 (de)
EP (1) EP1786921B1 (de)
JP (1) JP5191731B2 (de)
AT (1) ATE495439T1 (de)
AU (1) AU2005272814B2 (de)
CA (1) CA2576431C (de)
DE (1) DE602005025892D1 (de)
HK (1) HK1109427A1 (de)
WO (1) WO2006020766A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005025892D1 (de) 2004-08-12 2011-02-24 Neuro Probe Inc Punktquellendiffusionszellaktivitätstestvorrichtungen und -verfahren
US8082392B2 (en) * 2009-04-28 2011-12-20 Lsi Corporation Managing storage array operations that cause loss of access to mirrored data
JP5166360B2 (ja) * 2009-06-23 2013-03-21 株式会社島津製作所 マイクロ反応装置を用いた細胞運動評価方法
JP2012228183A (ja) * 2011-04-22 2012-11-22 Npo Keihanna Bunka Gakujutsu Kyokai 生物活性測定装置および最小生育阻止濃度推定方法
TWI640624B (zh) * 2014-08-29 2018-11-11 國立清華大學 細胞觀測裝置及使用其之細胞收集方法
EP3826345A1 (de) * 2015-02-11 2021-05-26 IPCom GmbH & Co. KG Verfahren und vorrichtung zum konfigurieren eines einzelfrequenznetzwerks
US10384207B2 (en) 2015-07-21 2019-08-20 Neuro Probe Incorporated Assay apparatus and methods
CN108798628B (zh) * 2018-04-27 2021-06-15 成都理工大学 基于毛管力作用的气液分离计量装置
CN112970738B (zh) * 2019-12-02 2023-08-11 深圳拜尔洛克生物技术有限公司 一种利用水凝胶向生物材料进行溶液投送的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200152A (en) * 1988-03-28 1993-04-06 Cytonix Corporation Miniaturized biological assembly
US4912057A (en) * 1989-06-13 1990-03-27 Cancer Diagnostics, Inc. Cell chamber for chemotaxis assay
US5763266A (en) * 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5210021A (en) * 1991-03-20 1993-05-11 Neuro Probe, Inc. Multiple-site chemotactic test apparatus and method
US5284753A (en) * 1991-03-20 1994-02-08 Neuro Probe, Inc. Multiple-site chemotactic test apparatus and method
US5302515A (en) * 1992-08-20 1994-04-12 Neuro Probe, Inc. Chemotactic test apparatus and method
US5514555A (en) * 1993-03-12 1996-05-07 Center For Blood Research, Inc. Assays and therapeutic methods based on lymphocyte chemoattractants
US5716849A (en) * 1994-06-08 1998-02-10 Novartis Finance Corporation Genes for the biosynthesis of soraphen
US5874301A (en) * 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5601997A (en) * 1995-02-03 1997-02-11 Tchao; Ruy Chemotaxis assay procedure
EP0727481B1 (de) * 1995-02-16 2003-04-16 Forschungszentrum Jülich Gmbh Verfahren zur Kultivierung von Organfunktionszellen
US6329164B1 (en) 1999-03-18 2001-12-11 Neuro Probe, Incorporated Method for using a cell activity assay apparatus
US6287340B1 (en) * 1999-05-14 2001-09-11 Trustees Of Tufts College Bioengineered anterior cruciate ligament
JP5943533B2 (ja) * 2000-05-17 2016-07-06 アステリアス バイオセラピューティクス インコーポレイテッド 神経前駆細胞の集団
AU2002239501A1 (en) * 2000-10-26 2002-06-03 University Of Connecticut A system and method for investigating the effect of chemical and other factors on cell movement
EP1356022B1 (de) * 2000-12-08 2008-01-23 Flexcell International Corporation Verfahren und vorrichtung zur zuchtung und mechanischen konditionierung von zellkulturen
AU2002335610C1 (en) * 2001-01-29 2008-09-25 Hemogenix, Inc. High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation
US7201873B2 (en) * 2001-04-16 2007-04-10 Tosoh Corporation Fine channel device, method for producing the fine channel device and use of the same
US7179643B2 (en) * 2001-06-14 2007-02-20 Reliance Life Sciences Pvt. Ltd. Device and a process for expansion of haemopoeitic stem cells for therapeutic use
US20030044879A1 (en) * 2001-08-28 2003-03-06 Michael Beyer Method and device for forming a concentration gradient for chemotactic evaluation through use of laminar flow
US7332029B2 (en) 2002-01-18 2008-02-19 Neuro Probe Incorporated Crystal forming apparatus and method for using same
EP1476592A4 (de) 2002-01-18 2007-10-24 Neuro Probe Inc Kristallherstellungsapparatur und verfahren zur verwendung der apparatur
US7232547B2 (en) * 2002-03-22 2007-06-19 Marshfield Clinic Apparatus and method for testing and continuously reading low-volume samples
US7091035B2 (en) * 2002-12-30 2006-08-15 The United States Of America As Represented By The Department Of Health And Human Services Cell culturing and storage systems, devices and methods
DE602005025892D1 (de) 2004-08-12 2011-02-24 Neuro Probe Inc Punktquellendiffusionszellaktivitätstestvorrichtungen und -verfahren

Also Published As

Publication number Publication date
WO2006020766A3 (en) 2006-05-18
US20060035311A1 (en) 2006-02-16
EP1786921B1 (de) 2011-01-12
CA2576431C (en) 2014-04-22
EP1786921A2 (de) 2007-05-23
JP5191731B2 (ja) 2013-05-08
US8129175B2 (en) 2012-03-06
AU2005272814B2 (en) 2010-12-23
HK1109427A1 (en) 2008-06-06
EP1786921A4 (de) 2007-12-05
JP2008509669A (ja) 2008-04-03
AU2005272814A1 (en) 2006-02-23
DE602005025892D1 (de) 2011-02-24
US8486655B2 (en) 2013-07-16
CA2576431A1 (en) 2006-02-23
US7547525B2 (en) 2009-06-16
US20090246860A1 (en) 2009-10-01
WO2006020766A2 (en) 2006-02-23
US20120122141A1 (en) 2012-05-17

Similar Documents

Publication Publication Date Title
ATE495439T1 (de) Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren
EP1947452A4 (de) Verfahren zum spezifischen nachweis einer testsubstanz mittels photostrom sowie elektrode, messzelle und messvorrichtung zur verwendung dafür
JP2009509168A5 (de)
WO2012074972A3 (en) Non-destructive testing methods for fuel cell interconnect manufacturing
MX2016002632A (es) Dispositivo y metodos para usar un dispositivo para la deteccion de hiperamoniemia.
EP3779436A3 (de) Verfahren zur erzeugung von ph/ionischen konzentrationsgradienten in der nähe von elektrodenoberflächen zur modulation von biomolekularen wechselwirkungen
MY141411A (en) Method and system for detecting leak in electronic devices
SG154410A1 (en) System and method for measuring an analyte in a sample
BRPI0507322A (pt) biosensor eletroquìmico
MX363201B (es) Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico.
ATE533855T1 (de) Testverfahren zum nachweis lebensfähiger mikrobenzellen in einer probe
EP3851856A3 (de) Verfahren, array und verwendung davon
ATE408829T1 (de) Verfahren und assaykits zum nachweis mononuklearer zellphänotypen
DE602006018432D1 (de) Antigennachweis
DK1989544T3 (da) T-celle-testmetode
ATE519858T1 (de) Biologischer bodendetektor und verfahren zur verwendung davon
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
ATE514082T1 (de) Biologischer bodendetektor
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул
ATE533053T1 (de) Nicht-elispot-test
ATE499598T1 (de) Markierungsfreier einzelzelltest
WO2011110955A3 (en) Methods of testing for intracellular pathogens
ATE475884T1 (de) Detektion von zirkulierenden endothelzellen
TW200739778A (en) A test structure and method for detecting charge effects during semiconductor processing using a delayed inversion point technique
MX2019010478A (es) Sistemas y métodos para la detección y cuantificación enzimáticas de a1c.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties